使用其他SGLT2抑制剂控制血糖良好的T2DM患者开始使用瑞格列净时血糖和额外血糖参数的变化

{"title":"使用其他SGLT2抑制剂控制血糖良好的T2DM患者开始使用瑞格列净时血糖和额外血糖参数的变化","authors":"","doi":"10.29011/2574-7568.010110","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":73707,"journal":{"name":"Journal of diabetes and treatment","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Variation in Glycemic and Extra Glycemic Parameters with Initiation of Remogliflozin Etabonate in Patients of T2DM Having a Good Glycemic Control with other SGLT2 Inhibitors\",\"authors\":\"\",\"doi\":\"10.29011/2574-7568.010110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":73707,\"journal\":{\"name\":\"Journal of diabetes and treatment\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of diabetes and treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.29011/2574-7568.010110\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes and treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29011/2574-7568.010110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}